Clinical trial

'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)

NCT04375904

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2020-12-22

PhasePHASE2

Study timeline

Study start (actual)2020-12-22Date precision: day

Registry last updated2025-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC/Oligometastatic Cancer (Single Lung Lesion)unresolved

Interventions

Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR)RADIATION

Sponsors & collaborators

Cancer Trials Irelandlead sponsor

Technological University Dublincollaborator

University College Dublincollaborator

Mapped research locations

DublinIreland2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04375904 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.